Should patients with rheumatic diseases take pain medication in order to engage in exercise?

Thumbnail
Name:
Metsios_Kitas_Should_patients_ ...
Embargo:
2021-01-28
Size:
147.2Kb
Format:
PDF
Download
Cast your vote
 
Your vote was cast
Thank you for your feedback
Authors
Metsios, GS
Kitas, GD
Issue Date
2020-01-28

Metadata
Show full item record
Abstract
Pain is the main symptom in most rheumatic and musculoskeletal diseases (RMDs). It has debilitating effects in terms of mobility, physical function, sleep, mood, fatigue, and overall quality of life. This is why pain and its associates are some of the predominant outcomes evaluated regularly in response to pharmaceutical or any other interventions involved in the management of RMDs.
Citation
Metsios, G.S. and Kitas, G.D. (2020) Should patients with rheumatic diseases take pain medication in order to engage in exercise? Expert Review of Clinical Immunology, 16(3), pp. 235-237.
Publisher
Taylor & Francis
Journal
Expert Review of Clinical Immunology
URI
http://hdl.handle.net/2436/623326
DOI
10.1080/1744666X.2020.1714438
PubMed ID
31928254 (pubmed)
Additional Links
https://www.tandfonline.com/doi/full/10.1080/1744666X.2020.1714438
Type
Journal article
Language
en
Description
This is an accepted manuscript of an article published by Taylor & Francis in Expert Review of Clinical Immunology on 28/01/2020, available online: https://doi.org/10.1080/1744666X.2020.1714438 The accepted version of the publication may differ from the final published version.
ISSN
1744-666X
EISSN
1744-8409
Collections
https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/